WEBINARS AND EVENTS Combining genetic and genomic testing in ovarian cancer through multidisciplinary collaboration Speakers: Dana M. Chase MD, FACOG Molly Lund MS, CGC Date: 09/24/2025 Duration: 1 hour CEU: Yes Please join us for our webinar where we will explore the latest advancements in ovarian cancer care and strategies for streamlining genetic and genomic testing for patients. Summarize the latest treatment recommendations for stage III–IV epithelial ovarian, fallopian tube, and primary peritoneal cancers. Advocate for consistent application of evidence-based guidelines to reduce variability in care. Promote shared decision-making and patient-centered care in the context of evolving therapies. Demonstrate how treatment and testing guidelines inform real-world decision-making using case studies. Hear from our Speakers Dana M. Chase MD, FACOG Dr. Chase is a Professor of Clinical Obstetrics and Gynecology in the Division of Gynecologic Oncology. She completed her medical degree, residency in obstetrics and gynecology and gynecologic oncology fellowship at the University of California, Irvine. Her clinical and research interests include clinical trials, chemotherapy, quality of life, the microbiome, health disparities, and geriatric oncology. Dr. Chase is a board-certified gynecologic cancer physician and surgeon. Molly Lund MS, CGC Molly Lund is a board-certified senior genetic counselor with DNAXPRT Consulting. She works as a clinical oncology genetic counselor in a community hospital setting with the Sarah Cannon Cancer Network at HCA Midwest Health. She obtained her Masters in Genetic Counseling from Northwestern University and has worked in clinical settings since that time, covering pediatric, prenatal and oncology clinics. She is also a clinical supervisor for students in the University of Kansas Genetic Counseling Program.